Cancer drug off NHS list26th June 2008
The government’s medical advisory body the National Institute for Clinical Health and Excellence (NICE) has advised against the NHS using Avastin after manufacturer Roche declined to answer requests for data on the drug’s clinical and cost effectiveness.
Avastin is used for lung and breast cancer but British patients now look as though they will miss out on the drug after the Swiss pharmaceuticals group refused to cooperate with NICE. The drug has already been rejected by NICE as not being cost effective for bowel cancer.
Share this page
There are no comments for this article, be the first to comment!
Post your comment
Only registered users can comment. Fill in your e-mail address for quick registration.
Title: Cancer drug off NHS list
Author: Mark Nicholls
Article Id: 7294
Date Added: 26th Jun 2008